The TACR3 gene helps nerve cells in the brain respond to a chemical signal that supports the release of hormones needed for puberty and fertility. This gene plays an important role in how the brain starts and maintains reproductive hormone signals, so if it does not work well, a person may have delayed or absent puberty, low estrogen or testosterone, and trouble conceiving. Some people with a disruptive variant in the TACR3 gene are diagnosed with isolated hypogonadotropic hypogonadism, a condition in which the brain sends too little signal to the ovaries or testes.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
TACR3Gene function
What if the gene works
The TACR3 gene helps brain cells respond to neurokinin B, a chemical messenger. This supports the release of hormones that guide puberty, menstrual cycles, sperm production, and fertility.
Risk
What if the gene does not work
Variants in the TACR3 gene can disrupt signals that start puberty, causing delayed or absent puberty, low sex hormone levels, and reduced fertility. Milder variants may cause partial delay, while more severe variants can lead to absent puberty.
Treatment
What does that mean for your treatment
No TACR3-specific treatment or drug-selection approach is currently established in clinical guidelines. Care is usually guided by a person’s symptoms, hormone levels, and goals, using standard hormone replacement or fertility treatment when needed rather than the TACR3 gene itself. The TACR3 gene is also being studied as a drug target because it helps control reproductive hormone signals.
Conditions associated with TACR3
Gene function
What if the gene works
Some brain cells use the TACR3 gene to pick up an important chemical message called neurokinin B. This signal helps cells communicate in a steady pattern, especially in the hypothalamus, a brain area that helps coordinate body rhythms. It is part of how the TACR3 gene helps control puberty signals and support normal reproductive hormone release.
The TACR3 gene provides instructions for a receptor, a docking site on the cell surface, that binds neurokinin B. Once this message is received, the cell can pass the signal inward and adjust its activity.
This receptor helps certain hypothalamus nerve cells send and receive timed signals. Those steady exchanges help keep communication between key hormone controlling cells organized.
By relaying neurokinin B signals, the TACR3 gene helps coordinate release of gonadotropin releasing hormone, or GnRH (a hormone that starts a hormone signal chain). This supports the normal timing of puberty and ongoing reproductive hormone rhythms.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TACR3 gene can change the shape of its receptor, reduce how well it reaches the cell surface, or weaken its response to neurokinin B, so cell signaling becomes less effective. Milder TACR3 gene variants and delayed puberty are often linked through partial receptor activity, while more disruptive variants may leave little or no signaling. This functional spectrum can influence whether puberty starts late, stalls, or is more fully absent.
How variants are linked to conditions
Pathogenic variants in the TACR3 gene are a well established cause of congenital hypogonadotropic hypogonadism, often with a normal sense of smell. People with this condition may have delayed or absent puberty, low sex hormone levels, and later fertility problems. TACR3 gene variants linked to delayed puberty have also been reported in some families, but the clearest association is with this inherited form of puberty and hormone deficiency.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, particularly when more than one gene and environmental influences play a role. In other situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TACR3, risk is mainly shaped by the specific gene change a person is born with, especially when changes affect both copies of the gene. There is not yet broadly confirmed evidence that lifestyle or environmental factors clearly increase or reduce TACR3-related risk, so personal concerns are best discussed with a doctor or genetic counselor.
Inheritance of TACR3 variants
TACR3-related conditions are usually inherited in an autosomal recessive pattern. In practical terms, TACR3 gene inheritance usually means a person inherits one nonworking copy of the TACR3 gene from each parent. If both parents carry one variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier like the parents, and a 25% chance of inheriting neither variant. Men and women can inherit and pass on TACR3 variants equally.
What does my TACR3 result mean for my family?
For TACR3, family meaning is usually discussed in the setting of an inherited condition that can delay or prevent normal puberty and affect fertility. This result often means parents may be healthy carriers, and brothers or sisters could also carry the same gene change or, in some families, also be affected. Close relatives may want to learn whether the same TACR3 change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find TACR3 variants, a lab analyzes DNA from a blood sample, saliva, or cheek swab by sequencing the TACR3 gene letter by letter. TACR3 genetic testing for delayed or absent puberty can show whether a variant in the TACR3 gene may be part of the explanation.
When should I consider getting a genetic test?
Genetic testing for the TACR3 gene may be worth considering when puberty is very delayed or does not start, especially with low hormone levels or a family history of the same pattern. It can also help explain some cases of infertility linked to the body not making enough signals to start puberty and support reproductive function.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many other factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It looks at gene-drug patterns to help explain why the same treatment can work differently from one person to another. For many medications, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TACR3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
Researchers identified the TACR3 gene during the wave of receptor discovery that expanded in the late 1980s and early 1990s, when scientists were mapping how nerve signaling molecules work in the body. Initially understood through laboratory studies of a newly recognized receptor family, it later gained clinical importance through human genetics. Building on this early work, scientists reported in 2009 that inherited TACR3 variants could underlie some cases of congenital hypogonadotropic hypogonadism, a finding that sharpened understanding of delayed or absent puberty. Over time, descriptions became more precise as additional families and variants were reported. These studies placed the TACR3 gene into the modern history of reproductive genetics.